Načítá se...
Effects of the MAML2 genetic variants in glioma susceptibility and prognosis
Background: Abnormal expression of the mastermind-like transcriptional co-activator 2 (MAML2) gene is oncogenic in several human cancers, including glioma. However, the relevance of MAML2 variants with glioma remains unknown. We aimed to investigate the role of MAML2 polymorphisms in glioma risk and...
Uloženo v:
| Vydáno v: | Biosci Rep |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Portland Press Ltd.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6822528/ https://ncbi.nlm.nih.gov/pubmed/31652449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20192091 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|